Kelley, R. K., Meyer, T., Rimassa, L., Merle, P., Park, J., Yau, T., . . . Abou-Alfa, G. K. (2020). Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma. Clin Cancer Res.
Citação norma ChicagoKelley, Robin Kate, et al. "Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib Versus Placebo in Patients With Advanced Hepatocellular Carcinoma." Clin Cancer Res 2020.
Citação norma MLAKelley, Robin Kate, et al. "Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib Versus Placebo in Patients With Advanced Hepatocellular Carcinoma." Clin Cancer Res 2020.